3 paragraphs of its Risk Factors mention Climate, against 4 the year before.
Compare companies, side by side
The same facts from the filings for each company in a group, where each stands among the others, and what each wrote about a topic in its latest 10-K.
- Sales growth
- +7.1%
- Gross margin
- 65%
- Operating margin
- 14%
- Net margin
- 9.6%
The 3 largest with CI, ranked among the group
Each corner is the share of Health care companies the company is above on that ratio. The dashed line is the middle of the group. A rank, not a score.
2 paragraphs of its Risk Factors mention Climate, against 2 the year before.
6 paragraphs of its Risk Factors mention Climate, against 9 the year before.
Health care: the same facts for each company
| Company | Revenue, 12 months | Sales growth | Gross / operating margin | Net margin | Debt / equity | Accounting items | Insider buys | Investors | Open |
|---|---|---|---|---|---|---|---|---|---|
| CIYou came from Cigna | $286.3B
|
+11% |
GM 21%OM 3.4%
|
2.1% | 0.68 | 0 of 4to read | 0 | 0 | 10-K |
| UNH UnitedHealth Group | $449.7B
|
+12% |
GM 88%OM 5.3%
|
3.5% | 0.71 | 1 of 5to read | 0 | 0 | 10-K |
| CVS CVS Health | $420.6B
|
+7.8% |
GM 44%OM 3.6%
|
2.6% | 0.75 | 0 of 6to read | 1 | 0 | 10-K |
| MCK McKesson | $418.8B
|
+12% |
GM 3.7%OM 1.6%
|
1.1% | - | 0 of 6to read | 0 | 0 | 10-K |
| COR Cencora | $332.8B
|
+9.3% |
GM 4.0%OM 0.9%
|
0.8% | 3.93 | 0 of 6to read | 0 | 0 | 10-K |
| CAH Cardinal Health | $257.8B
|
+14% |
GM 3.9%OM 1.0%
|
0.7% | - | 0 of 6to read | 0 | 0 | 10-K |
| CNC Centene Corporation | $203.9B
|
+19% |
GM 7.9%OM 0.5%
|
0.7% | 0.70 | 1 of 3to read | 0 | 0 | 10-K |
| ELV Elevance Health | $201.8B
|
+12% |
GM 89%OM 2.7%
|
2.5% | 0.69 | 0 of 3to read | 0 | 0 | 10-K |
| HUM Humana | $154.2B
|
+10% |
GM -OM 1.5%
|
0.8% | 0.66 | 1 of 4to read | 0 | 0 | 10-K |
| JNJ Johnson & Johnson | $99.3B
|
+6.0% |
GM 68%OM -
|
16% | 0.55 | 1 of 6to read | 0 | 0 | 10-K |
| LLY Eli Lilly | $86.5B
|
+45% |
GM 84%OM -
|
32% | 1.23 | 3 of 6to read | 0 | 0 | 10-K |
| HCA HCA Healthcare | $78.7B
|
+7.1% |
GM -OM -
|
8.6% | - | 0 of 6to read | 0 | 0 | 10-K |
| MRK Merck & Co. | $67.4B
|
+1.3% |
GM 72%OM -
|
3.6% | 1.20 | 2 of 6to read | 0 | 0 | 10-K |
| ABBV AbbVie | $66.0B
|
+8.6% |
GM 74%OM 32%
|
16% | - | 1 of 6to read | 0 | 0 | 10-K |
| PFE Pfizer | $63.6B
|
-1.6% |
GM 73%OM -
|
6.3% | 0.70 | 0 of 6to read | 0 | 0 | 10-K |
| BMY Bristol Myers Squibb | $50.0B
|
-0.2% |
GM 69%OM -
|
18% | 1.86 | 0 of 5to read | 0 | 0 | 10-K |
| ABT Abbott Laboratories | $48.2B
|
+5.7% |
GM 57%OM 14%
|
9.7% | 0.61 | 0 of 6to read | 0 | 0 | 10-K |
| TMO Thermo Fisher Scientific | $47.4B
|
+3.9% |
GM -OM 18%
|
15% | 0.79 | 0 of 6to read | 0 | 0 | 10-K |
| AMGN Amgen | $38.9B
|
+10.0% |
GM 71%OM 32%
|
24% | 3.76 | 1 of 6to read | 0 | 0 | 10-K |
| MDT Medtronic | $37.5B
|
+8.4% |
GM 65%OM 18%
|
14% | 0.56 | 0 of 6to read | 0 | 0 | 10-K |
| GILD Gilead Sciences | $31.0B
|
+2.4% |
GM 80%OM -7.6%
|
-12% | 2.01 | 0 of 6to read | 0 | 0 | 10-K |
| SYK Stryker Corporation | $26.3B
|
+11% |
GM 65%OM 21%
|
14% | 0.61 | 1 of 6to read | 0 | 0 | 10-K |
| DHR Danaher Corporation | $25.6B
|
+2.9% |
GM 59%OM 20%
|
17% | 0.53 | 0 of 6to read | 0 | 0 | 10-K |
| BDX Becton Dickinson | $22.5B
|
+8.2% |
GM 47%OM 11%
|
4.2% | 0.69 | 0 of 6to read | 0 | 0 | 10-K |
| GEHC GE HealthCare | $21.6B
|
+4.8% |
GM 40%OM 13%
|
10.0% | 0.86 | 2 of 5to read | 0 | 0 | 10-K |
| BSX Boston Scientific | $21.1B
|
+20% |
GM 69%OM 19%
|
17% | 0.47 | 1 of 6to read | 1 | 0 | 10-K |
| UHS Universal Health Services | $18.4B
|
+9.7% |
GM -OM 11%
|
8.0% | 0.75 | 0 of 5to read | 0 | 0 | 10-K |
| IQV IQVIA | $17.3B
|
+5.9% |
GM -OM 13%
|
8.1% | 2.41 | 0 of 5to read | 0 | 0 | 10-K |
| REGN Regeneron Pharmaceuticals | $16.9B
|
+1.0% |
GM -OM 29%
|
29% | 0.06 | 0 of 6to read | 0 | 0 | 10-K |
| VTRS Viatris | $14.7B
|
-3.0% |
GM 35%OM 0.0%
|
-4.1% | 0.97 | 0 of 5to read | 0 | 0 | 10-K |
| LH Labcorp | $14.6B
|
+7.2% |
GM 29%OM 10%
|
6.9% | 0.66 | 0 of 6to read | 0 | 0 | 10-K |
| DVA DaVita | $14.2B
|
+6.5% |
GM -OM 15%
|
6.5% | - | 1 of 6to read | 0 | 0 | 10-K |
| HSIC Henry Schein | $13.7B
|
+4.0% |
GM 32%OM 5.2%
|
3.1% | 1.12 | 1 of 6to read | 0 | 0 | 10-K |
| VRTX Vertex Pharmaceuticals | $13.0B
|
+8.9% |
GM 86%OM 33%
|
31% | 0.22 | 4 of 6to read | 0 | 0 | 10-K |
| DGX Quest Diagnostics | $11.8B
|
+12% |
GM 33%OM 15%
|
9.5% | 0.73 | 0 of 6to read | 0 | 0 | 10-K |
| BAX Baxter International | $11.6B
|
+5.7% |
GM 30%OM -1.9%
|
-6.2% | 1.45 | 1 of 6to read | 0 | 0 | 10-K |
| ISRG Intuitive Surgical | $11.6B
|
+21% |
GM 67%OM 28%
|
26% | - | 0 of 6to read | 0 | 0 | 10-K |
| BIIB Biogen | $10.3B
|
+2.2% |
GM 74%OM -
|
3.4% | 0.39 | 0 of 6to read | 0 | 0 | 10-K |
| ZTS Zoetis | $9.5B
|
+2.3% |
GM 72%OM -
|
26% | 2.74 | 1 of 6to read | 0 | 0 | 10-K |
| ZBH Zimmer Biomet | $8.6B
|
+7.2% |
GM 70%OM 14%
|
9.0% | 0.59 | 1 of 6to read | 0 | 0 | 10-K |
| SOLV Solventum | $8.2B
|
+0.9% |
GM 55%OM 5.5%
|
1.9% | 0.95 | 2 of 6to read | 0 | 0 | 10-K |
| A Agilent Technologies | $7.4B
|
+6.7% |
GM 54%OM 22%
|
20% | 0.54 | 1 of 6to read | 0 | 0 | 10-K |
| EW Edwards Lifesciences | $6.7B
|
+12% |
GM 78%OM 22%
|
15% | 0.06 | 0 of 6to read | 0 | 0 | 10-K |
| STE Steris | $6.2B
|
+8.7% |
GM 45%OM 19%
|
13% | 0.26 | 0 of 6to read | 0 | 0 | 10-K |
| INCY Incyte | $6.0B
|
+21% |
GM 93%OM 10%
|
6.7% | - | 1 of 6to read | 0 | 0 | 10-K |
| RMD ResMed | $5.7B
|
+9.9% |
GM 61%OM 33%
|
28% | 0.07 | 1 of 6to read | 0 | 0 | 10-K |
| WAT Waters Corporation | $5.6B
|
+7.0% |
GM 59%OM 4.7%
|
1.8% | 0.34 | 1 of 6to read | 0 | 0 | 10-K |
| DXCM Dexcom | $5.1B
|
+16% |
GM 63%OM 24%
|
19% | - | 2 of 6to read | 0 | 0 | 10-K |
| IDXX Idexx Laboratories | $4.7B
|
+10% |
GM 63%OM 32%
|
25% | 0.20 | 0 of 6to read | 0 | 0 | 10-K |
| ILMN Illumina, Inc. | $4.5B
|
-0.7% |
GM 68%OM 21%
|
20% | 0.57 | 2 of 6to read | 0 | 0 | 10-K |
| COO Cooper Companies | $4.2B
|
+5.1% |
GM 66%OM 13%
|
13% | 0.31 | 1 of 6to read | 5 | 0 | 10-K |
| MTD Mettler Toledo | $4.2B
|
+4.0% |
GM 60%OM -
|
22% | - | 0 of 6to read | 0 | 0 | 10-K |
| ALGN Align Technology | $4.2B
|
+0.9% |
GM 69%OM 15%
|
12% | - | 0 of 6to read | 0 | 0 | 10-K |
| CRL Charles River Laboratories | $4.0B
|
-0.9% |
GM -OM 4.0%
|
1.0% | 0.76 | 0 of 6to read | 1 | 0 | 10-K |
| VEEV Veeva Systems | $3.5B
|
+16% |
GM 75%OM 30%
|
29% | - | 0 of 5to read | 0 | 0 | 10-K |
| WST West Pharmaceutical Services | $3.4B
|
+6.3% |
GM 38%OM 23%
|
19% | 0.07 | 1 of 6to read | 0 | 0 | 10-K |
| PODD Insulet Corporation | $3.2B
|
+31% |
GM 72%OM 18%
|
13% | 0.61 | 1 of 4to read | 1 | 0 | 10-K |
| RVTY Revvity | $2.9B
|
+3.7% |
GM -OM 13%
|
8.6% | 0.36 | 1 of 6to read | 0 | 0 | 10-K |
| MRNA Moderna | $2.5B
|
-40% |
GM 28%OM -116%
|
-110% | 0.09 | 1 of 6to read | 0 | 0 | 10-K |
| TECH Bio-Techne | $1.2B
|
-0.4% |
GM 66%OM 20%
|
14% | 0.18 | 0 of 6to read | 0 | 0 | 10-K |
Growth against cash margin
The 14 largest by revenue. A bigger bubble is more revenue; the dashed lines are the median of these companies.
How to read this page
- A radar shows where a company ranks among its group on six ratios. A corner at the edge means it is above every other company on that ratio.
- A table row lists the facts as the filings give them: revenue, growth, margins, debt to equity, the accounting checks, insider buying and followed investors holding.
- A bubble to the right grew faster, and one higher up kept more of its sales as free cash flow.
- A bar is paragraphs that mention the topic this year, and the mark on it is last year.
Risk Factors and XBRL figures from each company's latest 10-K, read nightly from SEC EDGAR. Nothing here is a rating.
Climate: paragraphs that mention it
All 120 companies
Risk Factors paragraphs in each company's latest 10-K, most mentions first. The bar is this year and the mark is last year. 42 companies have no 10-K downloaded yet.
What the companies wrote
MRK Merck & Co., Inc.
11 paragraphs• Climate change or legal, regulatory or market measures to address climate change may negatively affect the Company’s business, results of operations, cash flows, financial condition, and prospects.
Item 1A, Risk Factors, 10-K Feb 24, 2026
Climate change or legal, regulatory or market measures to address climate change may negatively affect the Company’s business, results of operations, cash flows, financial condition, and prospects.
Item 1A, Risk Factors, 10-K Feb 24, 2026
ZTS Zoetis Inc.
10 paragraphsThe impacts from climate change may also impact Zoetis’ and our suppliers’ manufacturing processes. For example, clean water is needed to produce our products, and the effects from climate change could result in water supply interruptions and low water quality …
Item 1A, Risk Factors, 10-K Feb 12, 2026
There has been a broad range of proposed and promulgated state, national and international regulation aimed at reducing the effects of climate change. Such regulations apply or could apply in countries where we have interests or could have interests in …
Item 1A, Risk Factors, 10-K Feb 12, 2026
PFE PFIZER INC
9 paragraphs• A significant adverse change in legal factors or in the business climate that could affect the value of the asset. For example, a successful challenge of our patent rights would likely result in generic competition earlier than expected.
Item 7, MD&A, 10-K Feb 26, 2026
… While we are working to implement emission reduction plans to achieve our voluntary climate goals, various factors, including the long time horizons and commercial availability of new technologies to enable emission reductions, in the time and scale needed, may present …
Item 1A, Risk Factors, 10-K Feb 26, 2026
VTRS Viatris Inc
9 paragraphs• natural or man-made disasters, including droughts, floods, earthquakes, hurricanes, wildfires and the impact of climate change in the countries in which we or our partners and suppliers operate; and
Item 1A, Risk Factors, 10-K Feb 26, 2026
The effects of global climate change present risks to our business. Extreme weather, natural disasters, power outages, or other conditions caused by climate change could adversely impact our supply chain and the availability and cost of raw materials, water supply …
Item 1A, Risk Factors, 10-K Feb 26, 2026
BDX BECTON DICKINSON & CO
8 paragraphsClimate change and related sustainability efforts, or legal, regulatory or market measures to address these efforts, could adversely affect our business, financial condition or results of operations.
Item 1A, Risk Factors, 10-K Nov 25, 2025
• The impact of climate change, legal, regulatory or market measures to address climate change, such as regulation of greenhouse gas emissions, zero-carbon energy and sustainability mandates and related disclosure requirements, and additional taxes on fuel and energy, or related …
Item 7, MD&A, 10-K Nov 25, 2025
IDXX IDEXX LABORATORIES INC /DE
8 paragraphsClimate change, or legal, regulatory or market measures to address climate change, could adversely affect our business, financial condition, and results of operation
Item 1A, Risk Factors, 10-K Feb 20, 2026
Regulators, investors, customers, employees, and other stakeholders are focused on environmental, social, and governance matters, including climate-related issues; human capital matters; and responsible sourcing, human rights, and supply chain. Regulators in the U.S., Europe, and elsewhere are considering …
Item 1A, Risk Factors, 10-K Feb 20, 2026
Show all 120 companies' quotes
WAT WATERS CORP /DE/
8 paragraphsSustainability issues, including those related to climate change, may have an adverse effect on our business, financial condition and results of operations and damage our reputation.
Item 1A, Risk Factors, 10-K Feb 23, 2026
Sustainability issues, including those related to climate change, may have an adverse effect on our business, financial condition and results of operations and damage our reputation.
Item 1A, Risk Factors, 10-K Feb 23, 2026
BIIB BIOGEN INC.
7 paragraphs… For example, the E.U., California and certain other countries we do business in have promulgated climate disclosure rules that will generally require additional disclosure. These new rules collectively will impose additional disclosure requirements relating to climate-related risks and …
Item 1A, Risk Factors, 10-K Feb 6, 2026
We identify climate risk as the risk of loss arising from climate change which comprises both physical risk and transition risk. Physical risk considers how the physical impacts of climate change (e.g., increased frequency and intensity of storms, drought …
10-K, 10-K Feb 6, 2026
STE STERIS plc
7 paragraphsWe may be adversely affected by global climate change or by existing and future legal, regulatory or market responses to such change.
Item 1A, Risk Factors, 10-K May 29, 2026
The long-term effects of climate change are difficult to assess and predict. The impacts may include social and human effects (such as population dislocations or harm to health and well-being), compliance costs and transition risks (such as regulatory or technology changes) and others. The effects could impair, for example, the availability and cost of energy (including utilities), and we may bear losses as a result.
Item 1A, Risk Factors, 10-K May 29, 2026
UHS UNIVERSAL HEALTH SERVICES INC
7 paragraphs• the impact of severe weather conditions, including the effects of hurricanes, flash floods, wildfires and climate change;
Item 7, MD&A, 10-K Feb 25, 2026
… To the extent that significant changes in the climate occur in areas where our facilities are located, we may experience increased frequency of severe weather conditions or natural disasters or other changes to weather patterns, all of which may result …
Item 1A, Risk Factors, 10-K Feb 25, 2026
CVS CVS HEALTH Corp
6 paragraphsas active shooter situations, whether as a result of war or terrorism or otherwise, can have a material adverse effect on the U.S. economy in general, our industries, our vendors and us specifically. In particular, the long-term effects of climate change are expected to be widespread and unpredictable.
Item 1A, Risk Factors, 10-K Feb 10, 2026
… These risks vary widely by country and include varying regional and geopolitical business conditions and demands, government intervention and censorship, discriminatory regulation, climate change regulation, nationalization or expropriation of assets and pricing constraints. Our international operations need to meet country …
Item 1A, Risk Factors, 10-K Feb 10, 2026
GEHC GE HealthCare Technologies Inc.
6 paragraphsWe have established and publicly announced details of our sustainability program, including goals related to addressing climate change. While these goals reflect our current plans and aspirations, we may need to adjust or revise them in light of changes to …
Item 1A, Risk Factors, 10-K Feb 4, 2026
The risks of disruption described above, as well as the risks arising from war, geopolitical conflicts, government sanctions or trade controls, imposition of tariffs, natural disasters, climate change-related physical and transitional risks, actual or threatened public health crises, epidemics …
Item 1A, Risk Factors, 10-K Feb 4, 2026
GILD GILEAD SCIENCES, INC.
6 paragraphsClimate change and related natural disasters, as well as legal, regulatory, or market measures to address climate change, can negatively affect our business and operations.
Item 1A, Risk Factors, 10-K Feb 24, 2026
In addition, laws and regulations relating to climate change continue to evolve and may impose new or modified requirements on our operations. These requirements, which can differ across jurisdictions, subject us to many transition risks, including, for example, new or …
Item 1A, Risk Factors, 10-K Feb 24, 2026
WST WEST PHARMACEUTICAL SERVICES INC
6 paragraphsChanging climate, global climate change regulations and greenhouse gas effects may adversely affect our operations and financial performance.
Item 1A, Risk Factors, 10-K Feb 17, 2026
Failure to comply with these regulations could result in fines and could affect our business, financial condition, results of operations and cash flows. We could also face increased costs related to defending and resolving legal claims and other litigation related to climate change and any alleged impact of our operations on climate change.
Item 1A, Risk Factors, 10-K Feb 17, 2026
AMGN AMGEN INC
5 paragraphs• The effects of global climate change and related natural disasters could negatively affect our business and operations.
Item 1A, Risk Factors, 10-K Feb 13, 2026
The effects of global climate change and related natural disasters could negatively affect our business and operations.
Item 1A, Risk Factors, 10-K Feb 13, 2026
BAX BAXTER INTERNATIONAL INC
5 paragraphs• The effects of climate change, including legal, regulatory, or market measures related to climate change and other sustainability topics, could adversely affect our business, results of operations, financial condition, and cash flows.
Item 1A, Risk Factors, 10-K Feb 12, 2026
The effects of climate change, including legal, regulatory, or market measures related to climate change and other sustainability topics, could adversely affect our business, results of operations, financial condition, and cash flows.
Item 1A, Risk Factors, 10-K Feb 12, 2026
ISRG INTUITIVE SURGICAL INC
5 paragraphs• Climate change, natural disasters, or other events beyond our control could disrupt our business, financial condition, or results of operations.
Item 1A, Risk Factors, 10-K Feb 3, 2026
CLIMATE CHANGE, NATURAL DISASTERS, OR OTHER EVENTS BEYOND OUR CONTROL COULD DISRUPT OUR BUSINESS, FINANCIAL CONDITION, OR RESULTS OF OPERATIONS.
Item 1A, Risk Factors, 10-K Feb 3, 2026
JNJ JOHNSON & JOHNSON
5 paragraphsClimate change or legal, regulatory or market measures to address climate change may negatively affect our business and results of operations.
Item 1A, Risk Factors, 10-K Feb 11, 2026
Concern over climate change may also result in new or additional legal or regulatory requirements designed to reduce greenhouse gas emissions and/or mitigate the effects of climate change on the environment. If such laws or regulations are more stringent …
Item 1A, Risk Factors, 10-K Feb 11, 2026
MCK MCKESSON CORP
5 paragraphsWe may be adversely affected by global climate change or by regulatory or market responses to such change.
Item 1A, Risk Factors, 10-K May 8, 2026
temperatures, and business interruption due to weather events that may be attributable to climate change. These risks might have a materially adverse impact on our business operations and our financial position or results of operation.
Item 1A, Risk Factors, 10-K May 8, 2026
MRNA Moderna, Inc.
5 paragraphsClimate change or legal, regulatory or market measures to address climate change may negatively affect our business, results of operations and financial condition.
Item 1A, Risk Factors, 10-K Feb 20, 2026
• changes in a specific country’s or region’s political and cultural climate or economic condition;
Item 1A, Risk Factors, 10-K Feb 20, 2026
MTD METTLER TOLEDO INTERNATIONAL INC/
5 paragraphs… Additionally, rising insurance and operating expenses from climate-related disruptions could adversely affect our financial performance.
Item 1A, Risk Factors, 10-K Feb 6, 2026
We may be adversely affected by environmental and climate change laws, regulations, and expectations.
Item 1A, Risk Factors, 10-K Feb 6, 2026
SOLV Solventum Corp
5 paragraphsClimate change and the impacts of climate change may materially adversely affect Solventum’s business, results of operations, financial condition and cash flows.
Item 1A, Risk Factors, 10-K Feb 27, 2026
Additionally, the impacts of climate change may further influence customer preferences and requirements, such as increased demand for products with lower environmental footprints, and for companies to produce and demonstrate progress against greenhouse gas reduction plans and targets. Failure to provide climate-friendly products or demonstrate greenhouse gas reductions could result in loss of market share.
Item 1A, Risk Factors, 10-K Feb 27, 2026
TECH BIO-TECHNE Corp
5 paragraphsClimate change and/or related environmental risks, or legal or regulatory measures to address climate change and/or related environmental risks, may negatively affect us.
Item 1A, Risk Factors, 10-K Aug 24, 2026
… Concern over climate change can also result in new or additional legal or regulatory requirements designed to reduce greenhouse gas emissions or mitigate the effects of climate change on the environment. Any such new or additional legal or regulatory requirements …
Item 1A, Risk Factors, 10-K Aug 24, 2026
A AGILENT TECHNOLOGIES, INC.
4 paragraphs… In addition, many of our stakeholders have diverging demands, perspectives and preferences, including on topics such as climate change and diversity. We may not be able to meet the diverse expectations and demands of all of our stakeholders, which could …
Item 1A, Risk Factors, 10-K Dec 22, 2025
… Further, in the event that any future climate change legislation would require that stricter standards be imposed by domestic or international environmental regulatory authorities, we may be required to make certain changes and adaptations to our manufacturing processes and facilities …
Item 1A, Risk Factors, 10-K Dec 22, 2025
ALGN ALIGN TECHNOLOGY INC
4 paragraphsNatural disasters and extreme weather conditions (including those caused by climate change) can cause deaths, injuries and major public health crises, power outages, property damage, restrictions and shortages of food, water, shelter and medical supplies, telecommunications failures, materials scarcity, price …
Item 1A, Risk Factors, 10-K Feb 27, 2026
… We are also required to comply with disclosure obligations under the SEC’s long-standing climate change disclosure guidance and other SEC regulations, as well as the European Union’s Corporate Sustainability Reporting Directive (“CSRD”). If we fail to adopt …
Item 1A, Risk Factors, 10-K Feb 27, 2026
BSX BOSTON SCIENTIFIC CORP
4 paragraphsNatural disasters, extreme weather and other conditions caused by or related to climate change could adversely impact our supply chain, including manufacturing and distribution networks, the availability and cost of raw materials and components, energy supply, transportation, or other inputs …
Item 1A, Risk Factors, 10-K Feb 17, 2026
Our business and operations are subject to risks related to natural disasters, climate change and other extreme weather.
Item 1A, Risk Factors, 10-K Feb 17, 2026
COO COOPER COMPANIES, INC.
4 paragraphs… In October 2023, California adopted new carbon and climate-related reporting requirements for large public and private companies doing business in the state. Further, the SEC adopted a final rule on the Enhancement and Standardization of Climate-Related Disclosures in …
Item 1A, Risk Factors, 10-K Dec 5, 2025
Environmental, social and corporate governance issues, including those related to climate change and sustainability, may have an adverse effect on our business and damage our reputation.
Item 1A, Risk Factors, 10-K Dec 5, 2025
DHR DANAHER CORP /DE/
4 paragraphsClimate change, legal or regulatory measures to address climate change and other sustainability topics and any inability on our part to address the range of stakeholder expectations relating to climate change and other sustainability topics may negatively affect us.
Item 1A, Risk Factors, 10-K Feb 24, 2026
… Concern over climate change can also result in new or additional legal, regulatory or quasi-regulatory requirements designed to reduce greenhouse gas emissions, mitigate the effects of climate change on the environment and/or increase disclosures with respect thereto, such …
Item 1A, Risk Factors, 10-K Feb 24, 2026
MDT Medtronic plc
4 paragraphsClimate change or legal, regulatory or market measures to address climate change may materially adversely affect our financial condition and business operations.
Item 1A, Risk Factors, 10-K Jun 18, 2026
… Although it is difficult to predict and adequately prepare to meet the challenges to our business posed by climate change, concerns over climate change also could result in new laws or regulations that are more stringent than current legal or …
Item 1A, Risk Factors, 10-K Jun 18, 2026
CI Cigna Group
3 paragraphsMany factors, including geopolitical issues, future economic downturns, man-made disasters, natural disasters (including those as a result of climate change) and pandemics, availability and cost of credit, and other capital and consumer spending, can negatively impact the U.S …
Item 1A, Risk Factors, 10-K Feb 26, 2026
… Environmental, social and governance-related laws and regulations, including those aimed at restricting the consideration of these factors by companies and requiring climate- and sustainability-related disclosures, and related stakeholder expectations have resulted, and may in the future result, in …
Item 1A, Risk Factors, 10-K Feb 26, 2026
CNC CENTENE CORP
3 paragraphs… hospital and pharmaceutical costs, including new high-cost specialty drugs, unexpected events, such as natural disasters, the effects of climate change, acts of war or aggression, geopolitical instability, major epidemics, pandemics and their resurgence, or newly emergent diseases, new medical …
Item 1A, Risk Factors, 10-K Feb 17, 2026
• disasters, climate-related incidents, acts of war or aggression or major epidemics;
10-K, 10-K Feb 17, 2026
DXCM DEXCOM INC
3 paragraphsWhile we seek to partner with organizations that mitigate their business risks associated with climate change, we recognize that there are inherent risks related to climate change wherever business is conducted. Ensuring business resiliency through mitigating climate-related risks in …
Item 1A, Risk Factors, 10-K Feb 12, 2026
Increasingly, regulators, customers, investors, employees and other stakeholders are focusing on sustainability matters relating to businesses, including climate change and greenhouse gas emissions, human and civil rights, and diversity, equity and inclusion. These changing rules, regulations and stakeholder expectations may …
Item 1A, Risk Factors, 10-K Feb 12, 2026
EW Edwards Lifesciences Corp
3 paragraphsClimate change, or legal, regulatory or market measures to address climate change, may materially adversely affect our financial condition and business operations.
Item 1A, Risk Factors, 10-K Feb 25, 2026
… Concern over climate change could result in new legal or regulatory requirements designed to mitigate the effects of climate change on the environment. Such laws or regulations may result in increased compliance burdens and costs to meet the regulatory obligations …
Item 1A, Risk Factors, 10-K Feb 25, 2026
ILMN ILLUMINA, INC.
3 paragraphs… Events that would indicate impairment and trigger an interim impairment test include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance …
Item 7, MD&A, 10-K Feb 12, 2026
… For example, California has recently enacted new climate-related disclosure rules and requirements. The cost of complying with any new disclosure regimes is uncertain. In addition, climate change may impact our business by increasing operating costs due to additional regulatory …
10-K, 10-K Feb 12, 2026
LLY ELI LILLY & Co
3 paragraphs… Relevant external environmental factors include (i) tariffs, (ii) cost inflation and global transportation and logistics challenges; (iii) labor market dynamics; (iv) natural disasters (including increased instances or severity of natural disasters or other events that may be due to climate …
Item 1A, Risk Factors, 10-K Feb 12, 2026
Furthermore, there is a sustained focus by foreign, federal, state, and local regulatory and legislative bodies on legislation and policies relating to climate change, greenhouse gas emissions, carbon taxes, emissions trading schemes, sustainability, human rights and related due diligence, workforce …
Item 1A, Risk Factors, 10-K Feb 12, 2026
RMD RESMED INC
3 paragraphs… Natural disasters and other business disruptions could adversely affect our business and financial condition, and global climate change could result in certain types of natural disasters occurring more frequently or with more intense effects. The impacts of climate change may …
Item 1A, Risk Factors, 10-K Aug 13, 2026
• Climate change and natural disasters, or other events beyond our control, could negatively impact our business operations and financial condition.
Item 1A, Risk Factors, 10-K Aug 13, 2026
BMY BRISTOL MYERS SQUIBB CO
2 paragraphsThere is an increased focus by foreign, federal, state, and local regulatory and legislative bodies, investors and other stakeholders regarding environmental sustainability and social impact policies relating to climate change, regulating greenhouse gas emissions, carbon taxes, emissions trading schemes, sustainability …
Item 1A, Risk Factors, 10-K Feb 11, 2026
… securities, antitrust, Federal and state pricing, consumer protection, data privacy and other laws and regulations; (viii) environmental, health, safety and sustainability matters, including regulatory actions in response to climate change; and (ix) tax liabilities resulting from assessments from tax authorities.
Item 1A, Risk Factors, 10-K Feb 11, 2026
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
2 paragraphsIncreasing focus on environmental, social and governance (ESG) matters, including climate-related issues, may impact our business, financial results or stock price.
Item 1A, Risk Factors, 10-K Feb 18, 2026
… If we are not effective in addressing ESG matters affecting our business, or setting and meeting relevant sustainability and climate-related goals, including our approved greenhouse gas emissions reduction targets, which have been approved by the Science Based Targets Initiative …
Item 1A, Risk Factors, 10-K Feb 18, 2026
HSIC HENRY SCHEIN INC
2 paragraphsCalifornia has adopted stringent new climate disclosure requirements, as has the EU.
10-K, 10-K Feb 24, 2026
risks associated with climate change, including physical risks such as impacts from extreme weather
10-K, 10-K Feb 24, 2026
HUM HUMANA INC
2 paragraphs• catastrophes, including acts of terrorism, public health emergencies, epidemics or pandemics (such as COVID-19), or natural disasters (such as hurricanes and earthquakes) which could occur more frequently or with more intense effects as a result of the impact of global climate change;
Item 1A, Risk Factors, 10-K Feb 19, 2026
other supply chain disruptions (including disruptions that occur as a result of catastrophes, including acts of terrorism, public health emergencies, epidemics or pandemics (such as COVID-19), or natural disasters (such as hurricanes and earthquakes) which could occur more frequently or with more intense effects as a result of the impacts of global climate change), each of which could impact the availability or cost of supplying of such products.
Item 1A, Risk Factors, 10-K Feb 19, 2026
REGN REGENERON PHARMACEUTICALS, INC.
2 paragraphs… to regulatory requirements or actions, business interruptions, labor shortages or disputes, supply chain interruptions or constraints (including with respect to natural gas and other raw materials), contaminations, fire, climate change, natural disasters, acts of war or terrorism, or other problems.
Item 1A, Risk Factors, 10-K Feb 4, 2026
… Further, we may be unable to pursue our research and development efforts if the relevant facility were to cease operations due to fire, climate change, natural disasters, acts of war or terrorism, or other disruptions. Any related delays may interfere …
Item 1A, Risk Factors, 10-K Feb 4, 2026
TMO THERMO FISHER SCIENTIFIC INC.
2 paragraphs… An earthquake or other natural disaster (including the effects of climate change such as sea level rise, drought, flooding, wildfires and more intense weather events), could disrupt our operations, including the ability to fulfill supply obligations to our customers, or …
Item 1A, Risk Factors, 10-K Feb 26, 2026
… Competitive climates in many of the markets we serve are characterized by changing technology and customer demands that require continuing research and development. Our success primarily depends on the following factors:
10-K, 10-K Feb 26, 2026
UNH UNITEDHEALTH GROUP INC
2 paragraphs… Public health crises arising from natural disasters, such as wildfires, hurricanes, and snowstorms, or effects of climate change could impact our business operations and result in increased medical care costs. Government enactment of emergency powers in response to public health …
Item 1A, Risk Factors, 10-K Mar 2, 2026
… customer populations, increased cost of individual services, costs to deliver care, large-scale medical emergencies, the potential effects of climate change, pandemics, the introduction of new or costly drugs or increases in drug prices, treatments and technology, new treatment guidelines …
Item 1A, Risk Factors, 10-K Mar 2, 2026
ZBH ZIMMER BIOMET HOLDINGS, INC.
2 paragraphsCompanies across all industries are facing increasing scrutiny, and potentially negative actions, from investors, regulators, customers, employees and other stakeholders related to their corporate responsibility commitments, performance, and disclosures, including those related to climate change, social matters and governance standards …
Item 1A, Risk Factors, 10-K Feb 20, 2026
… Concerns over climate change and natural disasters have also resulted in, and may continue to result in, new laws or regulations that are more stringent than current legal or regulatory requirements, and we may experience increased compliance burdens and costs …
Item 1A, Risk Factors, 10-K Feb 20, 2026
ABBV AbbVie Inc.
1 paragraph• business interruptions stemming from natural disasters, such as climate change, earthquakes, hurricanes, flooding, fires, or efforts taken by third parties to prevent or mitigate such disasters; and
Item 1A, Risk Factors, 10-K Feb 20, 2026
ABT ABBOTT LABORATORIES
1 paragraph• climate and public health-related events, including global climate change, extreme weather and natural disasters, public health crises such as widespread outbreaks of infectious diseases, and the cost and availability of insurance due to any of the foregoing events;
Item 1A, Risk Factors, 10-K Feb 20, 2026
COR Cencora, Inc.
1 paragraph… widespread public health issues, such as infectious diseases; natural disasters and other catastrophic events such as earthquakes, floods, or severe weather, including as a result of climate change; government policy changes; and political events such as terrorism, political tensions, military …
Item 1A, Risk Factors, 10-K Nov 25, 2025
ELV Elevance Health, Inc.
1 paragraph… Furthermore, climate change could result in certain types of natural disasters occurring more frequently or with more intense effects, which could have a long-term impact on general economic conditions and the health benefits and pharmacy services industries in particular.
Item 1A, Risk Factors, 10-K Feb 6, 2026
IQV IQVIA HOLDINGS INC.
1 paragraph… continue to evaluate and mitigate our business risks associated with environmental events, and we recognize that there are inherent climate-related risks wherever business is conducted. Any of our office or IT systems locations may be vulnerable to the adverse …
Item 1A, Risk Factors, 10-K Feb 17, 2026
PODD INSULET CORP
1 paragraph… The collection, measurement, and reporting of environmental data is subject to evolving reporting standards, including California’s climate disclosure requirements, and similar regulations established by other international regulatory bodies, such as the Corporate Sustainability Reporting Directive in the European Union …
10-K, 10-K Feb 18, 2026
RVTY REVVITY, INC.
1 paragraph• changes to economic conditions arising from global health crises and pandemics, climate change, trade policy or from wars or conflicts.
Item 1A, Risk Factors, 10-K Feb 24, 2026
ACAD ACADIA PHARMACEUTICALS INC
0 paragraphsNot mentioned in the latest 10-K.
ACHC Acadia Healthcare Company, Inc.
0 paragraphsNot mentioned in the latest 10-K.
ADMA ADMA BIOLOGICS, INC.
0 paragraphsNot mentioned in the latest 10-K.
ADUS Addus HomeCare Corp
0 paragraphsNot mentioned in the latest 10-K.
AGIO AGIOS PHARMACEUTICALS, INC.
0 paragraphsNot mentioned in the latest 10-K.
ALKS Alkermes plc.
0 paragraphsNot mentioned in the latest 10-K.
ALNY ALNYLAM PHARMACEUTICALS, INC.
0 paragraphsNot mentioned in the latest 10-K.
AMRX Amneal Pharmaceuticals, Inc.
0 paragraphsNot mentioned in the latest 10-K.
AXSM Axsome Therapeutics, Inc.
0 paragraphsNot mentioned in the latest 10-K.
BBIO BridgeBio Pharma, Inc.
0 paragraphsNot mentioned in the latest 10-K.
BCRX BIOCRYST PHARMACEUTICALS INC
0 paragraphsNot mentioned in the latest 10-K.
BEAM Beam Therapeutics Inc.
0 paragraphsNot mentioned in the latest 10-K.
BHC Bausch Health Companies Inc.
0 paragraphsNot mentioned in the latest 10-K.
BKD Brookdale Senior Living Inc.
0 paragraphsNot mentioned in the latest 10-K.
BMRN BIOMARIN PHARMACEUTICAL INC
0 paragraphsNot mentioned in the latest 10-K.
BTSG BrightSpring Health Services, Inc.
0 paragraphsNot mentioned in the latest 10-K.
CAH CARDINAL HEALTH INC
0 paragraphsNot mentioned in the latest 10-K.
CAI Caris Life Sciences, Inc.
0 paragraphsNot mentioned in the latest 10-K.
CGON CG Oncology, Inc.
0 paragraphsNot mentioned in the latest 10-K.
CHE CHEMED CORP
0 paragraphsNot mentioned in the latest 10-K.
CON Concentra Group Holdings Parent, Inc.
0 paragraphsNot mentioned in the latest 10-K.
CORT CORCEPT THERAPEUTICS INC
0 paragraphsNot mentioned in the latest 10-K.
CRSP CRISPR Therapeutics AG
0 paragraphsNot mentioned in the latest 10-K.
CYTK CYTOKINETICS INC
0 paragraphsNot mentioned in the latest 10-K.
DGX QUEST DIAGNOSTICS INC
0 paragraphsNot mentioned in the latest 10-K.
DVA DAVITA INC.
0 paragraphsNot mentioned in the latest 10-K.
EHC Encompass Health Corp
0 paragraphsNot mentioned in the latest 10-K.
ELAN Elanco Animal Health Inc
0 paragraphsNot mentioned in the latest 10-K.
ENOV Enovis CORP
0 paragraphsNot mentioned in the latest 10-K.
ENSG ENSIGN GROUP, INC
0 paragraphsNot mentioned in the latest 10-K.
EXEL EXELIXIS, INC.
0 paragraphsNot mentioned in the latest 10-K.
GH Guardant Health, Inc.
0 paragraphsNot mentioned in the latest 10-K.
GKOS GLAUKOS Corp
0 paragraphsNot mentioned in the latest 10-K.
GMED GLOBUS MEDICAL INC
0 paragraphsNot mentioned in the latest 10-K.
GRAL GRAIL, Inc.
0 paragraphsNot mentioned in the latest 10-K.
HAE HAEMONETICS CORP
0 paragraphsNot mentioned in the latest 10-K.
HALO HALOZYME THERAPEUTICS, INC.
0 paragraphsNot mentioned in the latest 10-K.
HCA HCA Healthcare, Inc.
0 paragraphsNot mentioned in the latest 10-K.
HIMS Hims & Hers Health, Inc.
0 paragraphsNot mentioned in the latest 10-K.
ICUI ICU MEDICAL INC/DE
0 paragraphsNot mentioned in the latest 10-K.
IDYA IDEAYA Biosciences, Inc.
0 paragraphsNot mentioned in the latest 10-K.
INCY INCYTE CORP
0 paragraphsNot mentioned in the latest 10-K.
INSM INSMED Inc
0 paragraphsNot mentioned in the latest 10-K.
INSP Inspire Medical Systems, Inc.
0 paragraphsNot mentioned in the latest 10-K.
IONS IONIS PHARMACEUTICALS INC
0 paragraphsNot mentioned in the latest 10-K.
IRTC iRhythm Holdings, Inc.
0 paragraphsNot mentioned in the latest 10-K.
ITGR Integer Holdings Corp
0 paragraphsNot mentioned in the latest 10-K.
JAZZ Jazz Pharmaceuticals plc
0 paragraphsNot mentioned in the latest 10-K.
KRYS Krystal Biotech, Inc.
0 paragraphsNot mentioned in the latest 10-K.
KYMR Kymera Therapeutics, Inc.
0 paragraphsNot mentioned in the latest 10-K.
LGND LIGAND PHARMACEUTICALS INC
0 paragraphsNot mentioned in the latest 10-K.
LH LABCORP HOLDINGS INC.
0 paragraphsNot mentioned in the latest 10-K.
LIVN LivaNova PLC
0 paragraphsNot mentioned in the latest 10-K.
LMAT LEMAITRE VASCULAR INC
0 paragraphsNot mentioned in the latest 10-K.
LNTH Lantheus Holdings, Inc.
0 paragraphsNot mentioned in the latest 10-K.
MDGL MADRIGAL PHARMACEUTICALS, INC.
0 paragraphsNot mentioned in the latest 10-K.
MDLN Medline Inc.
0 paragraphsNot mentioned in the latest 10-K.
MEDP Medpace Holdings, Inc.
0 paragraphsNot mentioned in the latest 10-K.
MIRM Mirum Pharmaceuticals, Inc.
0 paragraphsNot mentioned in the latest 10-K.
MMSI MERIT MEDICAL SYSTEMS INC
0 paragraphsNot mentioned in the latest 10-K.
MSA MSA Safety Inc
0 paragraphsNot mentioned in the latest 10-K.
NBIX NEUROCRINE BIOSCIENCES INC
0 paragraphsNot mentioned in the latest 10-K.
NTRA Natera, Inc.
0 paragraphsNot mentioned in the latest 10-K.
NVST Envista Holdings Corp
0 paragraphsNot mentioned in the latest 10-K.
OCUL OCULAR THERAPEUTIX, INC
0 paragraphsNot mentioned in the latest 10-K.
OGN Organon & Co.
0 paragraphsNot mentioned in the latest 10-K.
SYK STRYKER CORP
0 paragraphsNot mentioned in the latest 10-K.
VEEV VEEVA SYSTEMS INC
0 paragraphsNot mentioned in the latest 10-K.
VRTX VERTEX PHARMACEUTICALS INC / MA
0 paragraphsNot mentioned in the latest 10-K.